← back to search

Yasuko Orba

Global Virus Network · JP
Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include Mosquito-borne diseases and control, Viral Infections and Vectors, SARS-CoV-2 and COVID-19 Research, and Viral gastroenteritis research and epidemiology.
h-index
42
citations
7,720
works
203
NIH funding
primary concept
Biology
email

Recent publications

Epidemiological, clinical, and virological characterizations of Yezo virus infections, an emerging tick-borne orthonairovirus disease in Japan.
2026cited by 0position: contributordoi
NS4B and NS5 mutations expand the temperature range permissive for the replication of dual-host affiliated insect-specific flaviviruses in mosquito cells.
2026cited by 0position: contributordoi
In Vitro Selection and Characterization of Tecovirimat-resistant Mpox Virus.
2026cited by 0position: contributordoi
Circulation of an emerging neurotropic tick-borne phenuivirus in brown bears and wildlife in northern Japan
2026cited by 0position: contributordoi
Antiviral effect of cetylpyridinium chloride on SARS-CoV-2 in patients with COVID-19: An Observational Study
Journal of Oral Biosciences 2026cited by 0position: contributordoi
Integrated <i>in vivo</i> and transcriptomic analyses of lethal Oropouche virus infection reveal suppression of pathogenic host responses by antiviral therapy
2026cited by 0position: contributordoi
SARS-CoV-2 uptake and inflammatory response in senescent endothelial cells are regulated by the BSG/VEGFR2 pathway.
2025cited by 1position: contributordoi
Spatial gene expression analysis reveals pathological niches in Japanese encephalitis virus neuroinvasion.
2025cited by 0position: contributordoi
Lipidated macrocyclic peptide S-880008 as a broad-spectrum SARS-CoV-2 fusion inhibitor
2025cited by 0position: contributordoi
Mosquito-borne alphaviruses in Zambia: Isolation and characterization of Eilat and Sindbis viruses
Virus Research 2025cited by 0position: contributordoi
Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model
eBioMedicine 2024cited by 19position: contributordoi
A wide distribution of Beiji nairoviruses and related viruses in Ixodes ticks in Japan
Ticks and Tick-borne Diseases 2024cited by 6position: contributordoi
Neuron-associated retroelement-derived protein Arc/Arg3.1 assists in the early stages of alphaherpesvirus infection in human neuronal cells.
2024cited by 3position: contributordoi
African lineage 1a West Nile virus isolated from crocodiles exhibits low neuroinvasiveness in mice
Journal of General Virology 2024cited by 1position: contributordoi
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters.
2023cited by 75position: contributordoi
Ecological Niche Modeling of <i>Aedes</i> and <i>Culex</i> Mosquitoes: A Risk Map for Chikungunya and West Nile Viruses in Zambia.
2023cited by 9position: contributordoi
Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain.
2023cited by 5position: contributordoi
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
2022cited by 585position: contributordoi
A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant)
Biochemical and Biophysical Research Communications 2022cited by 12position: contributordoi
An unusually long Rift valley fever inter-epizootic period in Zambia: Evidence for enzootic virus circulation and risk for disease outbreak.
2022cited by 10position: contributordoi
Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
2022cited by 9position: contributordoi
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
2022cited by 7position: contributordoi
Serological characterization of lineage II insect-specific flaviviruses compared with pathogenic mosquito-borne flaviviruses
Biochemical and Biophysical Research Communications 2022cited by 4position: contributordoi
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
2021cited by 179position: contributordoi
SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.
2021cited by 143position: contributordoi
A novel nairovirus associated with acute febrile illness in Hokkaido, Japan.
2021cited by 81position: contributordoi
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
2021cited by 70position: contributordoi
Serologic and molecular evidence for circulation of Crimean-Congo hemorrhagic fever virus in ticks and cattle in Zambia.
2021cited by 20position: contributordoi
5-Hydroxymethyltubercidin exhibits potent antiviral activity against flaviviruses and coronaviruses, including SARS-CoV-2
iScience 2021cited by 18position: contributordoi
Attenuated infection by a Pteropine orthoreovirus isolated from an Egyptian fruit bat in Zambia.
2021cited by 13position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 40 papers (2020–2026) · 29 papers (2020–2026) · 28 papers (2020–2026)Hirofumi Sawa · Hokkaido Institute of Public Health28 papers (2020–2026)Michihito Sasaki · Abbott (United States)23 papers (2020–2026)Edgar Simulundu · Golden Valley Agricultural Research Trust7 papers (2020–2023) · 7 papers (2021–2026)Keita Matsuno · Institute of Zoology of the Slovak Academy of Sciences7 papers (2021–2026)Takao Sanaki · Brigham and Women's Hospital6 papers (2021–2025)Ryo Nakao · Hokkaido University6 papers (2021–2026)Akihiko Sato · Hokkaido University5 papers (2021–2026)Yongjin Qiu · Hokkaido University5 papers (2020–2022) · 4 papers (2024–2026)Yukari Itakura · Hokkaido University of Science4 papers (2022–2026)Ayato Takada · Centre for Infectious Disease Research in Zambia4 papers (2021–2021)Hiroko Kobayashi · Hokkaido University4 papers (2023–2026)Masayuki Saijo · National Institute of Infectious Diseases3 papers (2021–2021)Yuki Maruyama · National Center for University Entrance Examinations3 papers (2022–2025)Yuki Eshita · Hokkaido University3 papers (2020–2022)Katsumi Maenaka · Hokkaido University3 papers (2021–2025)